Dr Saul Halpern qualified from the London Hospital Medical College (University of London) in 1987 with an additional first class honours degree in Pharmacology. He subsequently undertook higher medical training at St Bartholomew’s and Guy’s Hospitals London, prior to obtaining membership of the Royal College of Physicians. He then entered specialist training in Dermatology as Registrar at St Bartholomew’s Hospital, London in 1991 and spent a further year’s research fellowship investigating biochemical effects of steroids on the skin, before moving to Liverpool as senior registrar in 1995. In 1998 he was appointed as Consultant Dermatologist at The Medway Maritime Hospital, Gillingham, Kent and awarded Fellowship of the Royal College of Physicians (FRCP) in 2000.
Dr Halpern has continued as NHS consultant at The Medway NHS Foundation Trust where he acts as educational supervisor for trainee dermatologists as well as teaching junior hospital doctors, GP trainees, GPs and medical students. He is a core member of the Skin Cancer Multidisciplinary Team (MDT), which convenes weekly by video-link to discuss all regional skin cancer cases between the Dermatologists, Pathologists, Radiologists, Plastic Surgeons and Oncologists. He also runs a skin cancer screening clinic and 2 skin cancer operating lists weekly at Medway Maritime Hospital in addition to his other general dermatology clinics.
Dr Halpern has been involved in the development of Teledermatology (use of digital technology to remotely diagnose and advise on management of skin disease) since 2001 and is now widely considered as a national expert in the field. He has been chairman of the British Teledermatology Society from 2006 – 2018 and is currently chairman of the British Association of Dermatologists Teledermatology Sub-Committee. He is also the UK representative and Board member of the International Society of Teledermatology, acting as its President from 2014-16, and organiser of the 6th World Congress of Teledermatology in London 2016.
He has written and co-authored on numerous publications, and has been an invited reviewer of submitted papers for leading Dermatological journals including the British Journal of Dermatology, Clinical and Experimental Dermatology and European Journal of Dermatology and Veneriology.
Dr Halpern believes in a holistic approach to his patients and the importance of an excellent rapport in order to facilitate the optimal management for their skin conditions. He is a fastidious dermatological surgeon, insisting on the best cosmetic outcome to skin surgery wherever possible. Since 2003 he has developed an interest in cosmetic dermatology including the use of muscle relaxants (Botox), dermal fillers and chemical peels to improve the appearance of the skin and thereby reduce the effects of ageing and sun damage. Cosmetic procedures are generally carried out at the Spire Alexandra Hospital